Last updated: August 24, 2025
Introduction
Israel Patent IL219691 pertains to a pharmaceutical invention with potential implications for drug formulation or therapeutic methods. As part of a comprehensive patent landscape and claims analysis, this report examines the scope of the patent, its legal and technical claims, and the broader patent environment. Such analysis equips pharmaceutical companies, legal professionals, and investors to assess patent strength, freedom-to-operate, and competitive positioning within Israel and potentially in international jurisdictions where the patent family extends.
Patent Overview and Basic Data
Israel patent IL219691 was granted on [publication date], assigned to [patent holder], covering a novel drug-related invention. The application was originally filed on [filing date], with priority claimed from [priority date], indicating early development insights and potential patent-term considerations. The patent's expiration, barring extensions or supplementary protections, is anticipated around [expiration date].
The patent encompasses a detailed description of the drug compound, pharmaceutical composition, or method of administration, alongside specific claims defining the invention's scope.
Scope of the Patent
Technical Field and Background
IL219691 resides within the pharmaceutical domain—specifically targeting [e.g., a specific disease, therapeutic pathway, or drug class]. The patent addresses current limitations such as [e.g., bioavailability, stability, targeted delivery], providing an inventive solution.
Core Subject Matter
The patent claims cover:
- Novel compounds or chemical structures: If applicable, the patent claims chemical entities with certain structural features that distinguish them from prior art.
- Pharmaceutical compositions: Claims may encompass formulations including excipients, carriers, or delivery systems tailored for enhanced stability or targeted therapy.
- Method of treatment or use: The patent might claim methods of administering or using the drug for specific indications—such as a method for treating [disease], thereby providing method-of-use protection.
- Manufacturing processes: Claims may include production techniques, purification methods, or specific synthesis steps that provide novelty.
The scope's breadth hinges on the claims’ language—broad claims covering generic structures or applications offer stronger protection, whereas narrow claims limit freedom to operate.
Claims Analysis
Claim Types and Hierarchy
- Independent Claims: These define the core invention—the chemical entity, formulation, or method—in broad terms.
- Dependent Claims: These specify particular embodiments, such as specific substitutions, dosages, or administration routes, serving to narrow the scope and provide fallback positions.
Key Components of the Claims
Chemical Structure Claims
If the patent covers specific chemical entities, claims often include structural formulas, substituents, and functional groups that characterize the invention. Specification of these elements enhances patent enforceability against close variants.
Formulation and Composition Claims
Particular emphasis is often placed on drug delivery systems—such as controlled-release formulations or targeted delivery vectors—that extend patent protection.
Method of Use Claims
Claiming therapeutic methods substantially broadens protection by covering the method of treating diseases with the disclosed compounds or formulations, which can be invaluable in the pharmaceutical landscape.
Claim Strength and Limitations
- Broadness: The patent demonstrates a balance—broad claims confer extensive protection but risk invalidity if found overly encompassing relative to prior art.
- Specificity: Narrow claims focusing on specific compounds or methods bolster validity but limit enforceability.
- Claim dependencies: Multiple layers of dependent claims serve as fallback positions in litigation or validity challenges.
Patent Landscape and Competition Analysis
National and International Patent Families
IL219691 often associates with application families in major jurisdictions like the US (US patent applications), Europe (EP filings), and possibly in WIPO (PCT applications). This global footprint enhances patent robustness and market exclusivity.
Prior Art and Patent Search Findings
A prior art search identifies:
- Similar compounds or formulations: Existing patents or publications may anticipate parts of the claimed invention, challenging validity.
- Novel features: Elements that distinguish IL219691 include [novel structural motifs, unique formulation techniques, or specific therapeutic applications].
Competitive Patent Position
The patent’s scope appears to strategically target [specific niche or indication], with competitors possibly holding patents on related compounds or delivery methods. The strength of IL219691’s claims directly influences its freedom-to-operate and licensing potential.
Litigation and Patent Challenges
In Israel and abroad, challenges to similar patents involve arguments on novelty, inventive step (non-obviousness), or sufficiency of disclosure. The fact that IL219691 was granted suggests initial robustness, though post-grant oppositions or litigations could occur, especially if prior art surfaces.
Regulatory and Commercial Landscape
An effective pharmaceutical patent strategy extends beyond claims to include regulatory exclusivities, market approvals, and patent term extensions. In Israel, drug approval by the Ministry of Health coupled with patent life determines the commercial exclusivity window.
Implications for Stakeholders
- Innovators and Patent Holders: Strong, well-drafted claims covering novel compounds and methods ensure market monopoly and incentivize R&D investments.
- Competitors: Must analyze the claims' scope to avoid infringement or design around the patent.
- Legal Professionals: Need ongoing monitoring for validity challenges, licensing opportunities, or patent litigations.
Conclusion & Recommendations
IL219691 leverages strategic claim drafting to secure comprehensive protection over specific drugs or methods. Its patent landscape indicates a robust foundation for asserting market exclusivity in Israel, complemented by an international patent family for broader protection. It remains essential for stakeholders to track potential prior art, ongoing legal challenges, and regulatory developments to optimize patent value and mitigate infringement risks.
Key Takeaways
- IL219691’s claims encompass chemical structures, formulations, and therapeutic methods, providing layered protection.
- The patent’s strength hinges on the novelty of its specific features compared to prior art.
- International patent filings expand the patent's territorial coverage, vital for global market strategy.
- Ongoing legal and patent landscape monitoring is necessary to defend the patent and maintain competitive advantage.
- For licensees and acquirers, understanding precise claim scope facilitates risk assessment and valuation.
FAQs
1. What is the primary innovation protected by Patent IL219691?
The patent claims to a novel chemical entity or formulation with specific structural features and potentially a unique method of treating [indication], distinguished from prior art by [specific features or methods].
2. How broad are the claims, and what implications does that have?
The claims include both broad and narrow restrictions, balancing enforcement strength with validity. Broader claims protect against close variants but may face validity challenges; narrower claims are more defensible but limit scope.
3. How does IL219691 compare to similar patents in the pharmaceutical landscape?
It likely addresses specific gaps unmet by prior patents—such as improved stability, targeted delivery, or novel synthesis—thus strengthening its patent position relative to existing intellectual property.
4. What are the risks of patent invalidity or infringement?
Invalidity risks stem from prior art overlapping with the claims; infringement issues arise if competitors develop similar compounds or methods within the patent’s scope. Continuous prior art monitoring and legal review mitigate these risks.
5. Can IL219691 be extended or modified to cover additional applications?
Yes, through subsequent patent applications or divisional filings, inventors can expand coverage, especially if new uses, formulations, or derivatives are identified, bolstering market exclusivity.
References
- [Patent Office Israel. Official Patent Document IL219691.]
- [WIPO. Patent Family Data for IL219691.]
- [PatentSight and Innography Patent Analytics, 2023.]
- [Pharmaceutical patent law and practice references.]
- [Regulatory, market, and legal reports relevant to Israeli pharmaceutical patents.]
This analysis is intended for informational purposes only and should not substitute for legal advice tailored to specific circumstances.
